Veterinary

Veterinary medicine uses the MSO-PC structure where states impose a corporate practice of veterinary medicine (CPVM) doctrine, and doesn’t where they don’t. It is also the vertical where most of this wiki’s payments content is irrelevant, because there is no claims infrastructure — pet insurance reimburses the owner, not the practice.

​

Entity and doctrine specifics

CPVM exists in some states and not others, and the states that have it are a different set from the states with strong medical CPOM. There is no reliable inference from one to the other. Where CPVM applies, the structure mirrors human medicine: a veterinarian-owned professional entity practices, and a management company owned by anyone provides everything else. Where it does not, a lay entity can typically own the veterinary practice outright, no friendly PC, no MSA, no transfer restriction agreement. Oregon’s SB 951 carves veterinary out of its MSO restrictions, alongside dental and PT/OT.¹ Check the veterinary practice act and the veterinary board specifically. A state’s position on physician CPOM tells you nothing useful about its veterinary rules. Some states with no meaningful medical CPOM restrict veterinary ownership, and vice versa.

​

Why veterinary consolidation ran ahead

Veterinary roll-ups reached scale earlier and faster than most human-medicine equivalents, and the reasons are structural:

1. Many states have no CPVM doctrine, so acquirers could own practices directly, no friendly owner, no MSA, no CPOM risk, no succession mechanism.
2. No payer infrastructure. No credentialing, no payer contracts, no enrollment lead time. An acquired practice generates revenue on day one under new ownership, with no 90-to-180-day enrollment gap.
3. Cash-pay economics. Revenue is collected at the point of service. Days in AR is close to zero.
4. Fragmented ownership with a retiring-owner demographic.
5. No reimbursement rate risk. Prices are set by the practice, not negotiated with payers.

Points 2 through 5 together mean veterinary practices have far cleaner cash characteristics than human-medicine practices, which makes them easier to underwrite and to finance.

​

The payer half of this wiki mostly doesn’t apply

Stated plainly, because it saves you reading a lot of pages: Pet insurance does not change this. The dominant model is reimbursement to the owner: the client pays the practice in full, then submits to their insurer for reimbursement. The practice is not a party to the claim. A small number of arrangements pay practices directly, but they are the exception and they are not a claims infrastructure.

​

What matters instead

With the payer machinery absent, veterinary practice economics run on things human-medicine groups worry about less: Payment at the point of service. Essentially all revenue is collected at checkout, by card or cash. That makes card processing economics a first-order concern rather than a footnote — at 2–3% of nearly all revenue, processing cost is a material P&L line. Chargebacks matter more. High ticket sizes, emotionally charged circumstances, and outcome dissatisfaction produce disputes. A euthanasia or an unsuccessful emergency surgery generates disputes that no evidence packet resolves comfortably. Clear descriptors, signed estimates, and documented consent are the controls. See Chargebacks. Client financing and payment plans. Third-party financing is widely used for large unexpected bills. Understand who bears the credit risk and what the practice pays. Wellness plan subscriptions. Monthly-fee plans covering routine care are common and popular. Two things to get right:

• They are deferred revenue. Money collected for services not yet delivered is a liability, not earnings. Practices that book subscription cash as revenue overstate performance and understate obligations.
• In some states they may look like insurance, which is a regulated activity. Structure with counsel — this is a real question, not a theoretical one.

Inventory and pharmacy. Veterinary practices carry substantial inventory, pharmaceuticals, food, supplies, and dispense directly. That is working capital, margin, and a regulated activity (controlled substances, DEA registration) that most human outpatient practices don’t manage. Emergency and specialty referral. The referral relationship between general practices and specialty/emergency hospitals is central to the industry’s economics. Where state anti-kickback or fee-splitting statutes are not payer-limited, referral arrangements deserve the same scrutiny they’d get in human medicine.

​

Structuring notes

In a CPVM state, the structure is the standard one: veterinarian-owned PC, MSO providing everything else, MSA, transfer restriction agreement, per-state entities. Everything in The MSO-PC model applies. In a non-CPVM state, a lay-owned entity can typically own the practice directly, which is materially simpler and cheaper. A multi-state group will therefore often run a mixed structure: directly owned practices in permissive states, PC-plus-MSA structures in CPVM states. That mixed shape is unusual in human medicine and normal in veterinary. It does mean two operating models, two sets of books-keeping conventions, and care in consolidation. See One PC per state.

​

Launch pitfalls

1. Assuming the human-medicine CPOM answer applies
2. Building payer infrastructure you don’t need, no credentialing, no clearinghouse
3. Booking wellness plan subscriptions as revenue rather than deferred liability
4. Structuring wellness plans without checking state insurance law
5. Ignoring card processing economics when nearly all revenue is card
6. Underestimating chargeback exposure in emotionally charged cases
7. Overlooking inventory and controlled substance compliance
8. Assuming referral arrangements are unregulated because there’s no federal AKS exposure

​

Sources

1. Or. S.B. 951 (2025), with carve-outs including veterinary. Enrolled bill.